Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
about
Lyme DiseaseThe Past, Present, and (Possible) Future of Serologic Testing for Lyme DiseaseThe Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American ResearchA critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.Application of Bayesian decision-making to laboratory testing for Lyme disease and comparison with testing for HIVIdentification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme diseaseDecorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.Laboratory diagnosis of Lyme disease: advances and challengesEpidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada.Lyme disease testing by large commercial laboratories in the United States.Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.Development of a metabolic biosignature for detection of early Lyme disease.Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme DiseaseMatrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritisLyme disease caused by Borrelia burgdorferi with two homeologous 16S rRNA genes: a case report.Microfluidic biosensing systems using magnetic nanoparticles.Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease.Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of lyme disease with noncutaneous manifestations.Achieving molecular diagnostics for Lyme disease.Review: unraveling Lyme diseaseNervous system Lyme disease, chronic Lyme disease, and none of the above.Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy.Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology.Blood donor Borrelia burgdorferi sensu lato seroprevalence and history of tick bites at a northern limit of the vector distribution.Early Disseminated Lyme Disease Causing False Positive Serology for Primary Epstein-Barr Virus Infection - Report of 2 Cases.Significant variations in the seroprevalence of C6 ELISA antibodies in a highly endemic area for Lyme borreliosis: evaluation of age, sex and seasonal differences.Neuroborreliosis.C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.Lyme disease in the United Kingdom.Nervous system lyme disease: diagnosis and treatment.Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department.Seroreactivity to the C6 Peptide in Borrelia Miyamotoi Infections Occurring in the Northeastern United States.
P2860
Q22250895-8EB2A396-769E-4090-AAC0-520E4270E5EEQ28075680-66A0A8BB-3E0A-47BC-9661-2FF41234813DQ28354112-A5938FEC-388E-4691-9488-0C658FEB09C3Q30240203-81B29599-6FFD-404C-8DAA-F29CA4A4EACFQ30357899-C2E19CC2-39EF-44DA-9E4E-A01A2E622CA5Q33565276-8CFCD447-240A-4609-B812-39191036E9C6Q33601926-93DD1A55-0CEE-47E8-A928-C866662645A3Q34568050-5953124E-D91C-44E9-80AD-B456AD5EE4D6Q34701380-0232F286-2417-46B7-8F94-854EE46B0942Q35638551-9E2696F4-00D7-4CAC-AB5E-D6D2DFDF12A3Q36121502-C5DE2B9B-868F-4811-9610-5DC4EA653817Q36275562-249B76A7-859B-4653-A4E6-6CC86537BD4AQ36283952-C6FA99EA-86F6-45EE-B4B8-F823090FCA0EQ36297670-B317C919-E11D-49E5-B1B5-9C3E91B588CFQ36489385-C60A6CA2-BDFE-4FD2-9173-2281244B33E8Q36737157-CF94AB0E-1C86-4E98-8BAD-17B7B20E96A3Q36764399-E4654F67-FB8A-4BE7-994D-B72C3832B204Q36784433-964BE70B-9A51-496A-BABE-F693F33C728BQ36843172-D8969016-6075-4C69-8770-DA66BF98136EQ37225181-4F695108-B391-4715-90FE-3631A04A21DAQ37325470-87EA5203-11DD-4ABB-95AA-5E5B39C7AD2FQ37336154-F94E7C8E-745F-4DEC-824D-B0EAAB80BC0AQ38154932-0C5B8DBC-9D07-49ED-B2F5-74B3BC74CF49Q38223310-12E86423-6EA3-48A6-BF9D-BBD8671CFBF1Q38588148-2523F0D5-1CF9-4B6E-BF86-1F1655BEEBDEQ39128189-AE501D33-23A0-4C67-8C55-5A49FA30F501Q40096920-8CD234D6-736B-45BA-89C4-B173CC447DD9Q40160907-8F0B2F6A-4543-4A0B-B514-EB8F7EB09695Q40257045-424D4F57-A001-48EA-9DFD-9C1249C83920Q40324175-6CED1BF8-1AED-422C-AC3E-D4405D222583Q40436486-722A986A-5BF4-4E43-BA0B-C00AFE0A7781Q41121104-C65AE5DC-E01F-40B6-9224-267E49215789Q41637638-93F6BAA8-7E78-41EA-9991-E10D3C2D26F5Q42241649-DCE9846F-3704-4956-9785-4A6B6BE2581BQ44367190-37CE4D1A-A456-4F4C-A81A-24907EE2DE38Q45223445-3D06D5AD-FC6D-45CB-A3DC-670F05A5546FQ46836151-143074CF-8D13-4CB7-A302-E6996A542D96Q47920219-AA6939A0-485A-45B1-A2C1-EBCF13F49E74Q49628856-FB76B350-1A99-4955-BD4A-F2450CC24123Q49922011-D5FE7E58-D00A-4BC8-B0F7-6AB392245CC3
P2860
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Single-tier testing with the C ...... tier testing for Lyme disease.
@ast
Single-tier testing with the C ...... tier testing for Lyme disease.
@en
type
label
Single-tier testing with the C ...... tier testing for Lyme disease.
@ast
Single-tier testing with the C ...... tier testing for Lyme disease.
@en
prefLabel
Single-tier testing with the C ...... tier testing for Lyme disease.
@ast
Single-tier testing with the C ...... tier testing for Lyme disease.
@en
P2093
P2860
P1476
Single-tier testing with the C ...... tier testing for Lyme disease.
@en
P2093
Allen C Steere
Barbara J B Johnson
Gary P Wormser
J Stephen Dumler
John Nowakowski
Maria E Aguero-Rosenfeld
Martin Schriefer
Robert B Nadelman
P2860
P356
10.1016/J.DIAGMICROBIO.2012.09.003
P577
2012-10-11T00:00:00Z